Founded in 1980 in Montreal, Quebec, Canada, Nordivia Biopharmaceuticals specializes in research, development and manufacturing of high-purity peptides, combining scientific expertise, advanced analytical technology and rigorous quality control standards.

Each batch undergoes an analytical control program that includes, as applicable, HPLC/UPLC, LC-MS/MS, Peptide Mapping, Amino Acid Analysis (AAA), assay tests, bacterial endotoxins (LAL/BET) and sterility tests. Results are documented in a batch-specific Certificate of Analysis (COA).

All Nordivia batches have identification and traceability, allowing correlation of each product with its production documentation and respective analytical controls.

At Nordivia, quality goes beyond purity percentage. Molecular identity, structural integrity, assay, microbiological safety and traceability form an integrated control system developed to ensure consistency and reliability.

NORDIVIA BIOPHARMACEUTICALS
Advanced Peptide Science • Analytical Precision • Traceable Quality
Montreal • Quebec • Canada | Established 1980